High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia

Published:2023-11 Issue: Volume:217 Page:115809
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Oikonomou Athanasios^ORCID,Valsecchi Luigia,Quadri Manuel,Watrin Titus,Scharov Katerina,Procopio Simona,Tu Jia-Wey,Vogt Melina,Savino Angela Maria,Silvestri Daniela,Valsecchi Maria Grazia,Biondi Andrea,Borkhardt Arndt,Bhatia Sanil,Cazzaniga Giovanni^ORCID,Fazio Grazia,Bardini Michela,Palmi Chiara

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference76 articles.

1. Acute lymphoblastic leukaemia;Harrison;Best Pract. Res. Clin. Haematol.,2001

2. Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia;Inaba;J. Clin. Med.,2021

3. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children’s Oncology Group study;Nguyen;Leukemia,2008

4. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?;Izraeli;Br. J. Haematol.,2010

5. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study;Conter;Blood,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAX5 Alterations in a Consecutive Childhood B-Cell Acute Lymphoblastic Leukemia Cohort Treated Using the ALL IC-BFM 2009 Protocol;Cancers;2024-03-15

2. Down syndrome and leukemia: An insight into the disease biology and current treatment options;Blood Reviews;2023-11

3. A preface to the special issue “Pediatric tumors”;Biochemical Pharmacology;2023-11